Tower Research Capital LLC (TRC) - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$2,663,000
+890.0%
77,282
+380.7%
0.03%
+163.6%
Q2 2020$269,000
+607.9%
16,078
+781.0%
0.01%
+266.7%
Q3 2019$38,000
+375.0%
1,825
+393.2%
0.00%
Q1 2019$8,000
-81.8%
370
-79.9%
0.00%
-100.0%
Q4 2018$44,000
+41.9%
1,840
+62.5%
0.00%
+50.0%
Q3 2018$31,000
-63.1%
1,132
-49.3%
0.00%
-81.8%
Q4 2017$84,000
-36.8%
2,232
-58.4%
0.01%0.0%
Q3 2017$133,000
+411.5%
5,363
+334.3%
0.01%
+266.7%
Q4 2016$26,000
+1200.0%
1,235
+734.5%
0.00%
Q2 2016$2,000
-94.9%
148
-94.8%
0.00%
-100.0%
Q1 2016$39,000
+550.0%
2,860
+796.6%
0.01%
+500.0%
Q4 2015$6,000
-94.0%
319
-92.0%
0.00%
-90.0%
Q3 2015$100,0003,9640.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders